BlackRock Capital Allocation Term Trust (BCAT)
NYSE: BCAT · Real-Time Price · USD
14.79
+0.04 (0.27%)
At close: May 29, 2025, 4:00 PM
14.80
+0.01 (0.07%)
After-hours: May 29, 2025, 7:49 PM EDT
Company Description
BlackRock Capital Allocation Term Trust is a newly organized, non-diversified, closed-end management investment company with no operating history.
Its investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
The Trust is headquartered in Wilmington, DE.
BlackRock Capital Allocation Term Trust
| Country | United States |
| Founded | 2020 |
| Industry | Asset Management |
| Sector | Financials |
| CEO | John M. Perlowski |
Contact Details
Address: 50 Hudson Yards New York, New York 10001 United States | |
| Phone | 212 810 5300 |
Stock Details
| Ticker Symbol | BCAT |
| Exchange | NYSE |
| Reporting Currency | USD |
| CIK Code | 0001809541 |
| CUSIP Number | 09260U109 |
| ISIN Number | US09260U1097 |
Key Executives
| Name | Position |
|---|---|
| Christophe Capelli | Chief Executive Officer |
| Julien Buronfosse | Chief Financial Officer |
| Julien Buronfosse | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 28, 2025 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |
| May 23, 2025 | 40-17G/A | Filing |
| May 22, 2025 | DEF 14A | Other definitive proxy statements |
| May 9, 2025 | SCHEDULE 13D/A | Filing |
| Mar 17, 2025 | N-CEN | Filing |
| Mar 7, 2025 | N-CSR | Filing |
| Mar 3, 2025 | SCHEDULE 13D/A | Filing |
| Feb 25, 2025 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |
| Feb 18, 2025 | 40-17G | Filing |
| Jan 21, 2025 | SCHEDULE 13D/A | Filing |